CANAAF’s May 2024 Events
See CANAAF's upcoming support groups for May 2024. Meet others in your local community with alopecia and find support.
OLUMIANT® Receives Health Canada Approval, Becoming the Second Approved Treatment for Severe Alopecia Areata in Canada
Eli Lilly Canada Inc. announced today that OLUMIANT (baricitinib) received regulatory approval for its severe alopecia areata indication via Notice of Compliance (NOC) from Health Canada.
April 2024 Event: Navigate With Confidence
Join us at Navigate with Confidence, a full-day conference centered around alopecia areata and mental wellness.
CANAAF’s February 2024 Events
See CANAAF's upcoming support groups for February 2024. Meet others in your local community with alopecia and find support.
CANAAF’s January 2024 Events
See CANAAF's upcoming support groups for January 2024. Meet others in your local community with alopecia and find support.
LITFULO™ Receives Health Canada Approval, Becoming the First Approved Treatment for Severe Alopecia Areata in Canada
This press release was posted on Pfizer's website on December 4, 2023. A dual JAK3/TEC inhibitor, LITFULO™ (ritlecitinib) is approved